Set Cookies

Medtronic maakt op deze website gebruik van Google Analytics, een webanalysedienst die uw gebruik van de website analyseert door middel van het gebruik van cookies. Uw IP-adres wordt door Google geanonimiseerd waardoor tracking op individueel niveau technisch onmogelijk is.

Voor meer informatie verwijzen wij u naar ons Cookiebeleid.

Hieronder kunt u aangeven of u voornoemde cookies toestaat.

Cookies niet toestaan Cookies toestaan

Click here for English.

Medtronic uses Google Analytics, a web analysis service that uses cookies to analyze your use of this website. Google depersonalises your IP address, making tracking at an individual level technically impossible.

For further information, please refer to our cookie policy.

Below you can indicate whether you accept the aforementioned cookies.

Reject cookies Allow cookies

Klik hier voor Nederlands.

Company Overview

As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease — faced by families and healthcare systems today. But no one can do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes — Further, Together.

Founded in 1949 as a medical repair company, we're now among the world's largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 155 countries.

Company Facts

Founded 1949
Principal Executive Office Dublin, Ireland
Operational Headquarters Minneapolis, Minnesota, USA
Chairman and
Chief Executive Officer
CEO Omar Ishrak
Omar Ishrak
Therapy Groups and
Business Units
Cardiac and Vascular Group (CVG)
  • Aortic & Peripheral Vascular
  • Cardiac Rhythm & Heart Failure
  • Coronary & Structural Heart
Restorative Therapies Group (RTG)
  • Neuromodulation
  • Neurovascular
  • Orthopedics
  • Spine
  • Surgical Technologies
Minimally Invasive Therapies Group (MITG)
  • Early Technologies
  • Patient Monitoring & Recovery
  • Surgical innovations
Diabetes Group (DG)
  • Diabetes Services & Solutions
  • Intensive Insulin Management
  • Non-intensive Diabetes Therapies
Integrated Health Solutions℠ (IHS)
Employees 85,000+
Countries served 155+
Stock Exchange New York Stock Exchange (NYSE) under symbol MDT
FY2015* Financials

* FY2015 based on Medtronic fiscal year as reported and reflects the one-quarter contribution of the Covidien transaction which closed on January 26, 2015.
  • Net Sales: $20.261 billion
  • Net Earnings: $2.675 billion
  • R&D Investment: $1.64 billion
  • Declared Cash Dividends Per Share: $1.22

Section Navigation

Additional information

NYSE (MDT)

Medtronic was ranked number 18 in the list of Best Workplaces in the Netherlands in 2016!

Best Employer 2016

For more information greatplacetowork.nl

Integrated Performance Report van 2015

View or download the 2015 Integrated Performance Report

Annual Report SEC 10-K Filing for Fiscal Year 2015

Form 10-K Fiscal Year 2015

View or download the Annual Report SEC 10-K Filing for Fiscal Year 2015

Netherlands